Talking about those legal threats

The South Florida Business Journal reported on the boom in compounded GLP-1s and Scott explained why the threat of (baseless) lawsuits from pharma companies can keep some pharmacists from talking about it.

Bonus: Both Eli Lilly and Novo Nordisk admitted to threatening compounders even without legal basis.

Getting away from GLP-1s, Pharmaceutical Executive features CEO Scott Brunner and Chief Advocacy...

Self has a long, well-balanced article on not just the current state of GLP-1 compounding, but a...

Inside Health Policy covered our letter to FDA protesting the agency's recent (ridiculous)...

Talking about those legal threats

Related posts

PharmExec features APC execs talking about the compounding process

Self magazine has compounding story that gets into details

APC in IHP (on FDA FAERS)